Eurobio Scientific to sell PromarkerD predictive test for diabetic kidney disease in France
Find out more ➝

Proteomics International's Annual Report 2024
Find out more ➝

Proteomics International unveils groundbreaking study on type 1 diabetes and kidney health
Find out more ➝

Proteomics International appoints medical devices sales agency Growth Medics to further European expansion
Find out more ➝

Proteomics International signs agreement with University of Oxford to further validate 'PromarkerEndo' test for endometriosis
Find out more ➝

Proteomics’ new oesophageal cancer test presented at global conference
Find out more ➝
PromarkerD Analytical Services Diagnostics Investors

Newsroom

PIQ Announcements Investor Presentation – Pitt Street Research Life... Read more ➝ Blood test for kidney decline in Type 1 diabetes –... Read more ➝ Proteomics testing pinpoints future kidney disease risk... Read more ➝
Subscribe

  • This field is for validation purposes and should be left unchanged.
Menu